Image pharmaphorum Editor Webinars Sponsored Primary care sites: A new avenue for clinical research The primary care setting offers huge potential for commercial research. Others Digital transformation in pharma TEST Using AI to make a big impact for emerging and mid-sized biopharma companies Views & Analysis Haven: The strategy that didn't fix healthcare John Singer discusses the disbanding of Haven, the joint healthcare venture by Amazon, JP Morgan and Berkshire Hathaway, and the strategies that can help fix US healthcare. Views & Analysis 4 principles for the future of pharma marketing COVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing? Load more results
Webinars Sponsored Primary care sites: A new avenue for clinical research The primary care setting offers huge potential for commercial research.
Others Digital transformation in pharma TEST Using AI to make a big impact for emerging and mid-sized biopharma companies
Views & Analysis Haven: The strategy that didn't fix healthcare John Singer discusses the disbanding of Haven, the joint healthcare venture by Amazon, JP Morgan and Berkshire Hathaway, and the strategies that can help fix US healthcare.
Views & Analysis 4 principles for the future of pharma marketing COVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing?
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
